ABBV - AbbVie

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by T0rm3nted, Apr 9, 2016.

  1. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    AbbVie (ABBV) is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs. It originated in 2013 as a spin-off of Abbott Laboratories.

    AbbVie developed adalimumab, which is marketed under the trade name Humira, a biopharmaceutical treatment for autoimmune diseases that has exceeded $10 billion in global sales. AbbVie’s portfolio of medicines also includes AndroGel, Creon, Duodopa and Duopa, Kaletra, Lupron, Niaspan, Norvir, Sevoflurane, Synagis, Synthroid, TriCor and Trilipix, Viekira, and Zemplar.
     
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    Reported before open today (4/28/16)
    Earnings: EPS $1.15 Revenue $5.96B
    Estimates: EPS $1.13 Revenue $5.91B
     
  3. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    Ex-Div-Date: 7/13/16
    Payment Date: 8/15/16
    Dividend: $0.57
    Current Price: $61.92
    Annual Yield: 3.68%
     
  4. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    Analyst Upgrade/Downgrade Update

    Brokerage firm:
    Leerink Partners
    Change: Coverage Initiated
    Previous Rating: N/A
    Current Rating: Market Perform
    Previous Price Target: N/A
    Current Price Target: $70
     
  5. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    702
    Likes Received:
    63
    David Seaburg Is Bullish On AbbVie
    He said the company has an interesting cancer pipeline, which could provide a boost for the stock. He added that AbbVie has a 4 percent dividend yield and it trades at a discount at 14 times earnings.
    With positive news about the pipeline AbbVie could trade to $80, believes Seaburg.
     
  6. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    702
    Likes Received:
    63
  7. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    AbbVie stock slammed after disappointing results for cancer drug acquired in $5.8 billion deal
    Source: https://www.marketwatch.com/story/a...22?link=MW_widget_latestnews_stockaholics.net

    Down nearly 13% yesterday

    upload_2018-3-23_7-17-31.png
     
  8. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    For all you long-term investors, this is a current dividend aristocrat. The weekly chart shows this is sitting at the 200MA, so it may be a good entry point if you plan to hold for a long period of time (like the dividend aristocrats are intended to be held). Currently in a short/mid-term down trend, however. First chart is the weekly, second chart is the daily. Dividend Yield is 5%

    upload_2019-6-18_11-46-35.png

    upload_2019-6-18_11-49-22.png
     
    Three Eyes likes this.
  9. Three Eyes

    Three Eyes 2018 Stockaholics Contest Winner

    Joined:
    Dec 14, 2017
    Messages:
    485
    Likes Received:
    633
    ABBV today reaffirming the overall downward trend since early 2018. It'll be worth watching the coming weeks to see if it holds the bottom channel before resuming what I would expect to be continued decent swing-trade opportunities.

    Screenshot 2019-06-25 at 1.44.01 PM.png
     
    T0rm3nted likes this.
  10. Stockaholic

    Stockaholic Content Manager

    Joined:
    Mar 29, 2016
    Messages:
    13,767
    Likes Received:
    7,050
    Dividend Stock Spotlight: AbbVie (ABBV)
    Mon, Nov 11, 2019

    The Health Care sector has rebounded recently, and pharmaceutical stock AbbVie (ABBV) has rallied right alongside the sector. Since reaching its multi-year low around $62 in the middle of August, which also coincided with support from the top end of its former trading range, ABBV has surged over 37%. While it is currently pretty extended at over 2 standard deviations above its 50-DMA, the rally has broken what had been an 18-month downtrend from early 2018.

    One factor that weighed on the stock during that time was concerns over generic competition as the patent for the company's arthritis drug Humira—which makes up the bulk of the company's revenues—is set to expire in 2023. Despite that looming headwind, ABBV has made efforts to diversify its revenue sources including on-going discussions for the acquisition of Botox maker Allergan (AGN). Additionally, other product lines are experiencing considerable growth such as its cancer treatment Imbruvica which saw revenues over $1.25 billion in the most recent quarter; a 29.3% YoY growth rate.

    Even with the massive surge, ABBV is still the highest yielding stock in the S&P 500 Health Care sector. Yielding 5.54%, the next highest dividend in the sector is Pfizer (PFE) which yields 3.9%. That dividend is more than twice the size of the average S&P 500 and Health Care sector stock. Earlier this month, the company announced that the quarterly payout would be raised another 10%. Given that the payout ratio now sits at 84.1%, the ratio is getting a bit high, but the company's long dividend history makes this an easier pill to swallow. ABBV has now raised its dividend for 48 consecutive years (includes when the stock was part of Abbott Labs (ABT) from which it was spun off in 2013), making it a Dividend Aristocrat. Not only does ABBV belong to this group, but it also boasts the highest yield of all the aristocrats. For reference, ABBV's stock goes Ex-Dividend on January 14th, 2020.

    [​IMG]
     
  11. gtrudeau88

    gtrudeau88 Well-Known Member

    Joined:
    Dec 8, 2020
    Messages:
    712
    Likes Received:
    265
    ABBV gaining in pretrading, seemingly because both ARK and Berkshire Hathaway increased their stakes
     
    Rustic1 likes this.
  12. Rustic1

    Rustic1 Well-Known Member

    Joined:
    Jan 3, 2021
    Messages:
    1,143
    Likes Received:
    445
    Yep. If you notice BOTH always have cash on the side to better reposition. Wink wink.
     
  13. gtrudeau88

    gtrudeau88 Well-Known Member

    Joined:
    Dec 8, 2020
    Messages:
    712
    Likes Received:
    265
    I have a little cash now! I got rid of CVS yesterday cause it wasn't doing anything for me. I got a whole $3.46 capital gain from them.
     
    Rustic1 likes this.

Share This Page